Nirali Soni
SUNY Downstate Medical Center
3 Papers
13 Citations
Nirali Soni is an academic researcher from SUNY Downstate Medical Center. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Trends in HIV testing, the treatment cascade, and HIV incidence among men who have sex with men in Africa: a systematic review and meta-analysis.
James Stannah,Nirali Soni,J Lam,Katia Giguère,Kate M. Mitchell,Nadine Kronfli,Joseph Larmarange,Raoul Moh,Marcellin Nouaman,Gérard-Menan Kouamé,Marie-Claude Boily,Mathieu Maheu-Giroux +11 more
TL;DR: A systematic review of studies reporting HIV testing, knowledge of status, care, antiretroviral therapy (ART) use, viral suppression, and HIV incidence among MSM in Africa found insufficient evidence of a decrease in HIV incidence over time and strong evidence to suggest that viral suppression increased.
29
Effects of adjunctive lacosamide on mood and quality of life in patients with epilepsy
Luba Nakhutina,Saroj Kunnakkat,Madeleine Coleman,Catherine Lushbough,Vanessa Arnedo,Nirali Soni,Arthur C. Grant +6 more
TL;DR: Results suggest that LCM may have a favorable impact on mood, and there was a significant decrease in negative mood states in the LCM group, after controlling for seizure freedom.
17
Estimating the effect of HIV on cervical cancer elimination in South Africa: Comparative modelling of the impact of vaccination and screening
Marie-Claude Boily,Ruanne V. Barnabas,Minttu M Rönn,Cara J. Bayer,Cari van Schalkwyk,Nirali Soni,Darcy W. Rao,Lisa Staadegaard,Gui Liu,Romain Silhol,Marc Brisson,Leigh F. Johnson,Paul Bloem,Sami L. Gottlieb,Nathalie Broutet,Shona Dalal +15 more
TL;DR: In this paper , the authors assessed the impact of human papillomavirus vaccination and cervical cancer screening and treatment on cervical cancer and the potential for achieving elimination before 2120, considering faster HPV disease progression and higher cervical cancer risk among women living with HIV(WLHIV) and HIV interventions.
17